retatrutide phase 3 results october 2025 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist weight loss drug that is STILL IN CLINICAL TRIALS, is showing incredible results, with some retatrutide peptide | peptidesskin

Save the rest for later or let it go

They can help you weigh the benefits of increasing against your hesitation and create a plan that feels manageable

If you enjoyed this episode, don't forget to subscribe for more insightful discussions

These benefits persisted after adjusting for multiple potential confounders including baseline liver disease severity, comorbidities, and use of other medications [55]

Bottom line: MeAgain is for tracking and education

No red flags have emerged so far, but "no red flags in a small trial" is not the same as "proven safe in large populations." Will I regain weight after stopping either drug